We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-10.7%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$11.7B
AUM Growth
-$3.17B
Cap. Flow
-$1.15B
Cap. Flow %
-9.88%
Top 10 Hldgs %
46.25%
Holding
136
New
17
Increased
36
Reduced
23
Closed
34

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$440M
2
IQV icon
IQVIA
IQV
+$269M
3
AGN
Allergan plc
AGN
+$247M
4
GD icon
General Dynamics
GD
+$183M
5
FIS icon
Fidelity National Information Services
FIS
+$158M

Top Sells

Rank Stock Value
1
WCG
Wellcare Health Plans, Inc.
WCG
+$793M
2
MDCO
Medicines Co
MDCO
+$282M
3
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$236M
4
SPGI icon
S&P Global
SPGI
+$175M
5
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 51.69%
2 Communication Services 12.39%
3 Technology 10.92%
4 Industrials 5.44%
5 Financials 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VCYT icon
51
Veracyte
VCYT
$3.8B
$33.4M 0.29%
1,375,000
+375,000
+38% +$9.44M
PGNX
52
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$31.4M 0.27%
8,250,000
– –
TVRD
53
Tvardi Therapeutics
TVRD
$23.4M
$30.4M 0.26%
63,889
– –
ARWR icon
54
Arrowhead Research
ARWR
$12.4B
$28.8M 0.25%
1,000,000
+900,000
+900% +$36.3M
FSCT
55
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
$27.6M 0.24%
+875,000
New +$27.4M
TECX
56
Tectonic Therapeutic
TECX
$606M
$26.8M 0.23%
143,750
+14,583
+11% +$3.43M
RDUS
57
DELISTED
Radius Health, Inc.
RDUS
$26.7M 0.23%
2,054,486
– –
ZEAL
58
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$25.9M 0.22%
750,000
-259,800
-26% -$9.05M
KPTI icon
59
Karyopharm Therapeutics
KPTI
$48M
$25.6M 0.22%
+89,000
New +$24.5M
NVTA
60
DELISTED
Invitae Corporation
NVTA
$25.6M 0.22%
1,875,300
+125,300
+7% +$2.29M
MNTA
61
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$22.9M 0.2%
842,683
-1,907,317
-69% -$53.1M
PRNB
62
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$22.8M 0.2%
384,674
-15,326
-4% -$893K
TCDA
63
DELISTED
Tricida, Inc. Common Stock
TCDA
$22M 0.19%
1,000,000
– –
MYOK
64
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$20.2M 0.17%
430,000
-1,620,000
-79% -$104M
SAGE
65
DELISTED
Sage Therapeutics
SAGE
$19.4M 0.17%
675,000
+175,000
+35% +$10.1M
BX icon
66
Blackstone
BX
$110B
$18.4M 0.16%
+402,811
New +$22.3M
BRMK
67
CALL
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$18M 0.15%
+2,391,536
New +$26.4M
CRSP icon
68
CRISPR Therapeutics
CRSP
$5.17B
$14.8M 0.13%
350,000
– –
AMRN
69
Amarin Corp
AMRN
$303M
$14.5M 0.12%
181,250
-25,000
-12% -$8.31M
ATRA icon
70
Atara Biotherapeutics
ATRA
$76.1M
$12.8M 0.11%
60,000
+46,612
+348% +$14.8M
QURE icon
71
uniQure
QURE
$3.22B
$11.9M 0.1%
250,000
+50,000
+25% +$2.87M
STML
72
DELISTED
Stemline Therapeutics, Inc.
STML
$11.4M 0.1%
2,350,000
– –
KRYS icon
73
Krystal Biotech
KRYS
$9.66B
$10.8M 0.09%
+250,000
New +$13.1M
PTGX icon
74
Protagonist Therapeutics
PTGX
$9.44B
$10.6M 0.09%
1,500,000
– –
SVRA icon
75
Savara
SVRA
$1.19B
$10.2M 0.09%
4,825,086
– –
1 2
3
4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Farallon Capital Management held 136 positions worth $11.7B, down 21% from $14.8B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Farallon Capital Management withdrew a net $1.15B in Q1 2020, closing 34 positions and reducing 23 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $793M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 38% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Farallon Capital Management opened a new position in Centene worth $431M.

  • Farallon Capital Management's largest Q1 2020 buy was Centene: 7,250,000 shares worth $431M.
  • Farallon Capital Management added most to IQVIA in Q1 2020, an estimated $269M increase.
  • Farallon Capital Management's biggest Q1 2020 reduction was MyoKardia, Inc. Common Stock, cutting an estimated $104M.
  • Farallon Capital Management fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $793M.
  • Farallon Capital Management's ten largest holdings make up 46% of its $11.7B portfolio in Q1 2020.
  • Farallon Capital Management opened 17 new positions and closed 34 in Q1 2020.
  • Farallon Capital Management's portfolio value fell 21% quarter-over-quarter to $11.7B.

Based on Farallon Capital Management's 13F filing for Q1 2020, filed 15 May 2020.